Endoscopic Ultrasound in the Diagnosis of Extrahepatic Cholangiocarcinoma: What Do We Know in 2023?

Extrahepatic cholangiocarcinoma (CCA) is a rare and aggressive type of cancer, presenting as a mass or as a biliary stricture. This review summarizes the utility of endoscopic ultrasound (EUS) in the detection, staging, and determination of the differential diagnosis, especially when no cause of bil...

Full description

Bibliographic Details
Main Authors: Rares Ilie Orzan, Cristina Pojoga, Renata Agoston, Radu Seicean, Andrada Seicean
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/6/1023
_version_ 1797612412293087232
author Rares Ilie Orzan
Cristina Pojoga
Renata Agoston
Radu Seicean
Andrada Seicean
author_facet Rares Ilie Orzan
Cristina Pojoga
Renata Agoston
Radu Seicean
Andrada Seicean
author_sort Rares Ilie Orzan
collection DOAJ
description Extrahepatic cholangiocarcinoma (CCA) is a rare and aggressive type of cancer, presenting as a mass or as a biliary stricture. This review summarizes the utility of endoscopic ultrasound (EUS) in the detection, staging, and determination of the differential diagnosis, especially when no cause of bile duct dilatation is revealed by cross-sectional imaging. The EUS detection rate for distal CCAs is higher than that for the proximal CCAs. The accuracy of T staging varies between 60 and 80%, and vascular involvement is correctly assessed by conventional EUS. EUS-tissue acquisition from the primary tumors is reserved for unresectable or metastatic CCA, especially in distal strictures or mass CCAs. For proximal lesions, EUS could be performed as an adjunctive to ERCP sampling when the latter is inconclusive. EUS is not appropriate for assessing the malignant features of lymph nodes in CCAs. Lymph node EUS-tissue acquisition should be performed only if it changes the surgical decision. Perhaps the development of EUS-fine needle biopsy and the detection of molecular genetic alteration will increase the diagnostic yield in CCAs.
first_indexed 2024-03-11T06:41:52Z
format Article
id doaj.art-784584d073e14f67a7273168875f9dac
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-11T06:41:52Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-784584d073e14f67a7273168875f9dac2023-11-17T10:33:17ZengMDPI AGDiagnostics2075-44182023-03-01136102310.3390/diagnostics13061023Endoscopic Ultrasound in the Diagnosis of Extrahepatic Cholangiocarcinoma: What Do We Know in 2023?Rares Ilie Orzan0Cristina Pojoga1Renata Agoston2Radu Seicean3Andrada Seicean4Department of Internal Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, RomaniaRegional Institute of Gastroenterology and Hepatology “Prof. Dr. Octavian Fodor”, 400162 Cluj-Napoca, RomaniaFaculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, RomaniaFirst Department of Surgery, Iuliu Hațieganu University of Medicine and Pharmacy, 400000 Cluj-Napoca, RomaniaDepartment of Internal Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, RomaniaExtrahepatic cholangiocarcinoma (CCA) is a rare and aggressive type of cancer, presenting as a mass or as a biliary stricture. This review summarizes the utility of endoscopic ultrasound (EUS) in the detection, staging, and determination of the differential diagnosis, especially when no cause of bile duct dilatation is revealed by cross-sectional imaging. The EUS detection rate for distal CCAs is higher than that for the proximal CCAs. The accuracy of T staging varies between 60 and 80%, and vascular involvement is correctly assessed by conventional EUS. EUS-tissue acquisition from the primary tumors is reserved for unresectable or metastatic CCA, especially in distal strictures or mass CCAs. For proximal lesions, EUS could be performed as an adjunctive to ERCP sampling when the latter is inconclusive. EUS is not appropriate for assessing the malignant features of lymph nodes in CCAs. Lymph node EUS-tissue acquisition should be performed only if it changes the surgical decision. Perhaps the development of EUS-fine needle biopsy and the detection of molecular genetic alteration will increase the diagnostic yield in CCAs.https://www.mdpi.com/2075-4418/13/6/1023extrahepatic cholangiocarcinomaendoscopic ultrasoundendoscopic retrograde cholangiopancreatography
spellingShingle Rares Ilie Orzan
Cristina Pojoga
Renata Agoston
Radu Seicean
Andrada Seicean
Endoscopic Ultrasound in the Diagnosis of Extrahepatic Cholangiocarcinoma: What Do We Know in 2023?
Diagnostics
extrahepatic cholangiocarcinoma
endoscopic ultrasound
endoscopic retrograde cholangiopancreatography
title Endoscopic Ultrasound in the Diagnosis of Extrahepatic Cholangiocarcinoma: What Do We Know in 2023?
title_full Endoscopic Ultrasound in the Diagnosis of Extrahepatic Cholangiocarcinoma: What Do We Know in 2023?
title_fullStr Endoscopic Ultrasound in the Diagnosis of Extrahepatic Cholangiocarcinoma: What Do We Know in 2023?
title_full_unstemmed Endoscopic Ultrasound in the Diagnosis of Extrahepatic Cholangiocarcinoma: What Do We Know in 2023?
title_short Endoscopic Ultrasound in the Diagnosis of Extrahepatic Cholangiocarcinoma: What Do We Know in 2023?
title_sort endoscopic ultrasound in the diagnosis of extrahepatic cholangiocarcinoma what do we know in 2023
topic extrahepatic cholangiocarcinoma
endoscopic ultrasound
endoscopic retrograde cholangiopancreatography
url https://www.mdpi.com/2075-4418/13/6/1023
work_keys_str_mv AT raresilieorzan endoscopicultrasoundinthediagnosisofextrahepaticcholangiocarcinomawhatdoweknowin2023
AT cristinapojoga endoscopicultrasoundinthediagnosisofextrahepaticcholangiocarcinomawhatdoweknowin2023
AT renataagoston endoscopicultrasoundinthediagnosisofextrahepaticcholangiocarcinomawhatdoweknowin2023
AT raduseicean endoscopicultrasoundinthediagnosisofextrahepaticcholangiocarcinomawhatdoweknowin2023
AT andradaseicean endoscopicultrasoundinthediagnosisofextrahepaticcholangiocarcinomawhatdoweknowin2023